Publications by authors named "E van Duinkerken"
Over the past decades, life expectancy of people with type 1 diabetes has increased considerably, which brings potential challenges due to the process of aging. Cognitive aging and dementia, as well as reductions in visual acuity, hearing and dexterity, can influence the frequency and quality of daily self-management activities, including medication taking and insulin dosing, glucose self-monitoring, and healthy eating. This can increase the risk for hypo- and hyperglycemic events, which, in turn, may contribute to cognitive decline.
View Article and Find Full Text PDFBurnout syndrome is characterized by exhaustion, cynicism, and reduced effectiveness. Workers with high burnout scores who continue their professional activities are identified as experiencing non-clinical burnout (NCB), which includes early stages where burnout symptoms (BNS) are present but not yet severe enough to necessitate work leave. This study aimed to investigate the impact of BNS on attention performance among healthcare workers (HCWs) at a COVID-19 reference hospital during the pandemic.
View Article and Find Full Text PDFObjective: Depressive symptoms can be assessed with self-reported questionnaires, such as the Patient Health Questionary-9 (PHQ-9). Previous studies have suggested that the PHQ-9 items can be grouped into somatic and non-somatic clusters. However, the classification of the PHQ-9 item "concentration difficulties" into somatic or non-somatic is still controversial.
View Article and Find Full Text PDFArticle Synopsis
- The study investigated attention deficits in patients with obstructive sleep apnea (OSA) during a Go/No-Go task, focusing on whether these deficits worsened over time and were influenced by target frequency and stimulus speed.
- Patients with OSA showed lower alertness and longer reaction times compared to controls throughout the task, indicating persistent attention issues that did not escalate as the test progressed.
- The findings highlight that the main attention deficit in OSA lies in the alertness subdomain, independent of task conditions, raising concerns about the impact on daily activities, such as driving.
Background: Changes in brain connectivity occur in patients with multiple sclerosis (MS), even in patients under disease-modifying therapies. Using magnetic resonance imaging (MRI) to asses patients treated with disease-modifying therapies, such as natalizumab, can elucidate the mechanisms involved in clinical deterioration in MS.
Objectives: To evaluate differences in resting-state functional connectivity among MS patients treated with natalizumab, MS patients not treated with natalizumab, and controls.